# Basiliximab (Genetical Recombination) for I.V. Injection 10mg (シムレクト小児用静注用１０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6399418D2020). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6399418D2020
- **Product name (Japanese):** シムレクト小児用静注用１０ｍｇ
- **English title:** Basiliximab (Genetical Recombination) for I.V. Injection 10mg
- **Active ingredient:** バシリキシマブ（遺伝子組換え）
- **Active ingredient (INN):** Basiliximab (Genetical Recombination)
- **Strength / unit:** １０ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 63 Biological products (生物学的製剤) › 639 Other biological products (その他の生物学的製剤)
- **Manufacturer:** Novartis Pharma (ノバルティス ファーマ)
- **NHI price (reference only):** JPY 104504 per １０ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6399418D2020
- **JSON:** https://www.nifujipharma.com/api/drugs/6399418D2020

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Basiliximab%20(Genetical%20Recombination)%20for%20I.V.%20Injection%2010mg%20(%E3%82%B7%E3%83%A0%E3%83%AC%E3%82%AF%E3%83%88%E5%B0%8F%E5%85%90%E7%94%A8%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%91%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%206399418D2020#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Basiliximab (Genetical Recombination)

- [Basiliximab (Genetical Recombination) for I.V. Injection 20mg (シムレクト静注用２０ｍｇ)](https://www.nifujipharma.com/drugs/6399418D1032) — ２０ｍｇ１瓶, Novartis Pharma